Cell therapy continues to transform the oncology field, and this year has also seen the translation of cell therapies’ curative potential into the autoimmune space.
300+ industry experts will brainstorm enhancing target discovery, optimizing durability of response and identifying biomarkers to support recruitment, automating production, and accelerating analytical processes to reduce operational costs and turnaround times.
With a new Biopharma & Investors Evening, a new C-Level Think Tank, new speakers and data from Mnemo Therpaeutics, Cellectis, Bambino Gesu Hospital and more, can your team afford to miss out?
To know more visit: https://ter.li/6vgioi